Nulife Pharmaceuticals Private Limited

Nulife Pharmaceuticals Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U99999MH1975PTC018356 Incorporated 31 May 1975 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma
Revenue · FY 2024
₹17.55 Cr
▲ 6% YoY
Net profit · FY 2024
₹11.2 Lakh
Net margin 0.6%
EBITDA · FY 2024
₹13.75 Lakh
EBITDA margin 0.8%
Authorised capital
₹80 Lakh
Registered with MCA
Paid-up capital
₹75.02 Lakh
Issued & subscribed
Open charges
₹1.03 Cr
Secured borrowings
Company age
51 yrs
Est. 1975
Directors on board
2
As per MCA filings

About Nulife Pharmaceuticals Private Limited

Data last updated:

Nulife Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 31 May 1975 and has been in existence for over 51 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U99999MH1975PTC018356. Its GSTIN is 27AAACN2589C1ZJ (Maharashtra).

The company has an authorised share capital of ₹80 Lakh and a paid-up capital of ₹75.02 Lakh. It is led by directors Umesh Jayantilal Trivedi (Managing Director) and Anuradha Umesh Trivedi.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1 Nisarga Apartments Veer Makarand Ghanekar Marg (Azad Road) Vile Parle (East), Mumbai, Maharashtra, India – 400057.

As per the financials filed for FY 2024, the company reported a revenue of ₹17.55 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹11.2 Lakh (net margin 0.6%) and EBITDA of ₹13.75 Lakh (EBITDA margin 0.8%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 7% over five years.

As per MCA filings, the company has open charges of ₹1.03 Cr on record. The company has 5 deals on record (3 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹5 Lakh; the latest was in March 2016. Its 3 peer companies in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading) are compared by revenue, 2 larger and 1 smaller; the largest is R'keon Life Sciences Private Limited with revenue of ₹17.7 Cr.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website nulifepharma.com.

Company details

CIN U99999MH1975PTC018356
Registration Number 018356
Incorporation Date 31 May 1975
ROC Mumbai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

Nulife Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its website is nulifepharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    1 Nisarga Apartments Veer Makarand Ghanekar Marg (Azad Road) Vile Parle (East), Mumbai, Maharashtra, India – 400057
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Nulife Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Nulife Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Nulife Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Nulife Pharmaceuticals Private Limited, buy the company report.

Financials of Nulife Pharmaceuticals Private Limited

FY 2025 filings available

Nulife Pharmaceuticals Private Limited reported revenue of ₹17.55 Cr (up 6% YoY) for FY 2024.

Revenue · FY 2024
₹17.55 Cr ▲ 6%
Net profit · FY 2024
₹11.2 Lakh margin 0.6%
EBITDA · FY 2024
₹13.75 Lakh margin 0.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 6%
3 years · compounded
▲ 9%
5 years · compounded
▲ 7%
EBITDA CAGR growth
1 year
▲ 70%
3 years · compounded
▲ 38%
5 years · compounded
▲ 2%

Revenue has grown at a compounded annual rate (CAGR) of 7% over five years, including 6% growth in the latest year. EBITDA rose 70% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations₹17.55 Cr
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹13.75 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹11.2 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin0.8%
Net Profit Margin0.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Nulife Pharmaceuticals Private Limited, buy the company report.

Board of directors of Nulife Pharmaceuticals Private Limited

Nulife Pharmaceuticals has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Anuradha Umesh TrivediDirector01 Apr 201016 Years 7 MonthsCurrent
Umesh Jayantilal TrivediManaging Director30 Jun 198442 Years 4 MonthsCurrent

Peer comparison

Nulife Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
R'keon Life Sciences Private Limited₹17.7 Cr (FY 2024)-10.0%Allahabad, Uttar Pradesh, India
Aarsh Remedies Private Limited₹17.64 Cr (FY 2025)34.0%Ahmedabad, Gujarat, India
Nulife Pharmaceuticals Private Limitedthis company₹17.55 Cr (FY 2024)₹11.2 Lakh0.6%6.0%Mumbai, Maharashtra, India
Harasha Pharma Private Limited₹17.49 Cr (FY 2025)-35.0%New Delhi, Delhi, India

To see the full peer comparison of Nulife Pharmaceuticals Private Limited, buy the company report.

Auditor

Nulife Pharmaceuticals Private Limited is audited by TARJANI MALDE & CO for the financial year 2024.

Auditor firmFinancial yearFirm registration number
TARJANI MALDE & COFY 2024140544W

Shareholding

The shareholding of Nulife Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Nulife Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹1.03 Cr
Satisfied charges
None
Breakdown by lending institutions
Bank of India₹0.83 Cr
Bank of Indai₹0.20 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
14 May 200710084185Bank of India₹10 LakhOpen
14 May 200710124778Bank of India₹73 LakhOpen
23 Mar 199190367063Bank of Indai₹18.35 LakhOpen
29 Jun 198490366802Bank of Indai₹2 LakhOpen

To see the full charge records of Nulife Pharmaceuticals Private Limited, buy the company report.

Total charge records: 4 View all charges

Deals & funding

Nulife Pharmaceuticals Private Limited has 5 deals on record (3 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹5 Lakh; the latest was in March 2016.

Total deals
5
Secondary share transfers
3
Rights issue
1
Funding round
1
Disclosed funding
₹5 Lakh

Deals on record (5 of 5)

WhenDealAmountParties
Mar 2016Rights issue₹48 LakhInvestors: an individual
Jan 2014Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Mar 2010Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Mar 2010Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Feb 2009Funding round₹5 LakhInvestors: an individual

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Nulife Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Nulife Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAACN2589C1ZJMaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Nulife Pharmaceuticals Private Limited, buy the company report.

Recent activity

Nulife Pharmaceuticals Private Limited has 7 board changes on record since 1984: 2 appointments and 5 cessations. The latest: Nalin Janardan Desai ceased to be Director on 28 Apr 2016.

AGM
Nulife Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Nulife Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Nalin Janardan Desai ceased to be Director.
Ceased
Vinodrai Narmadashankar Pandya ceased to be Director.
Ceased
Anuradha Umesh Trivedi ceased to be Additional Director.
Appointed
Anuradha Umesh Trivedi was appointed as Director.
Ceased
Umesh Jayantilal Trivedi ceased to be Director.
Ceased
Jayantilal Ambalal Trivedi ceased to be Managing Director.
Charges
A charge with Bank Of India of Rs. 73.00 Lakh registered on 14 May 2007 with Charge ID 10124778 was modified on 28 Apr 2009.
Charges
A charge with Bank Of India amounted to Rs. 10.00 Lakh with Charge ID 10084185 was registered on 14 May 2007.
Charges
A charge with Bank Of India amounted to Rs. 73.00 Lakh with Charge ID 10124778 was registered on 14 May 2007.
Charges
A charge with Bank Of Indai amounted to Rs. 18.35 Lakh with Charge ID 90367063 was registered on 23 Mar 1991.

3 earlier events are in the company report.

Frequently asked questions

Nulife Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 31 May 1975 (51+ years old) and is registered under CIN U99999MH1975PTC018356.

Nulife Pharmaceuticals has 2 current directors:

The latest financial statements of Nulife Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Nulife Pharmaceuticals is 27AAACN2589C1ZJ, registered in Maharashtra.

The CIN (Corporate Identification Number) of Nulife Pharmaceuticals is U99999MH1975PTC018356. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Nulife Pharmaceuticals was incorporated on 31 May 1975, making it 51+ years old. It is registered with the Registrar of Companies, Mumbai.

Nulife Pharmaceuticals has 5 deals on record (3 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹5 Lakh; the latest was in March 2016.

The peers of Nulife Pharmaceuticals by revenue are R'keon Life Sciences Private Limited, Aarsh Remedies Private Limited, Harasha Pharma Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).

Nalin Janardan Desai ceased to be Director on 28 Apr 2016. Vinodrai Narmadashankar Pandya ceased to be Director on 28 Apr 2016. Anuradha Umesh Trivedi ceased to be Additional Director on 30 Sep 2010. Nulife Pharmaceuticals has 7 board changes on record in total.

Nulife Pharmaceuticals can be reached through the website nulifepharma.com. Its registered office is in Mumbai, Maharashtra, India.

The registered office of Nulife Pharmaceuticals is at 1 Nisarga Apartments Veer Makarand Ghanekar Marg Azad Road Vile Parle East, Mumbai, Maharashtra, India – 400057.